Ixazomib Impurity 30 CAS CATO-C4X-126730
| CAS No. | CATO-C4X-126730 |
| Molecular Formula | C39H45B3Cl6N6O9 |
| Molecular Weight | 986.96 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a process- or degradation-related impurity, Ixazomib Impurity 30 (CAS CATO-C4X-126730, C39H45B3Cl6N6O9) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Ixazomib Impurity 30 (C39H45B3Cl6N6O9) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. It is notably hygroscopic, halogen substitution raises its density and boiling point, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
As a certified reference material (CRM), Ixazomib Impurity 30 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C39H45B3Cl6N6O9 |
| Molecular Weight | 986.96 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 17.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 6 |
Related Ixazomib Standards
- Ixazomib Impurity 85 (CAS CATO-C4X-126785)
- Ixazomib Impurity 29 (CAS 1201903-03-8)
- Ixazomib Impurity 84 (CAS CATO-C4X-126784)
- Ixazomib Impurity 74 (CAS CATO-C4X-126774)
- Ixazomib Impurity 25 (CAS CATO-C4X-126725)
- Ixazomib Impurity 26 (CAS CATO-C4X-126726)
- Ixazomib Impurity 27 (CAS CATO-C4X-126727)
- Ixazomib Impurity 28 (CAS CATO-C4X-126728)
Recommended Standards
- 4,4',4'',4''',4'''',4'''''-(9,10-Dihydro-9,10-[1,2]benzenoanthracene-2,3,6,7,14,15-hexayl)hexakis(2-fluorobenzaldehyde) (CAS 2739864-54-9)
- N,N'-(((6,12-Dioxo-6,12-dihydronaphtho[7,8,1,2,3-nopqr]tetraphene-4,10-diyl)bis(azanediyl))bis(9,10-dioxo-9,10-dihydroanthracene-4,1-diyl))dibenzamide (CAS 6049-19-0)
- 4-Methylumbelliferyl -β-D-Cellopentoside (CAS 84325-20-2)
- Abz-(Asn670,Leu671)-Amyloid β/A4 Protein Precursor770 (669-674)-EDDnp (CAS 1007306-20-8)
- Finerenone Impurity 182-d5 (CAS CATO-C4X-2880182)
- Lefamulinum Impurity 30 (CAS CATO-C4X-304730)
- Valproate Impurity 80 (CAS CATO-C4X-116680)
- Monoisohexyl Phthalate (CAS 848131-14-6)
- N-(3,4-Dimethoxyphenyl)-2-((4-ethyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)acetamide (CAS 587010-85-3)
- 3-(1,1-Dioxidotetrahydrothiophen-2-yl)propanoic acid (CAS 1781310-91-5)
- 4-(Difluoromethyl)-5-fluoro-3-iodo-2-methylpyridine (CAS 1805192-70-4)
- 4-Fluoro-2-nitro-5-(1h-pyrazol-1-yl)aniline (CAS 1014020-15-5)
- 3-(5-((4-Bromobenzyl)thio)-4-(4-bromophenyl)-4H-1,2,4-triazol-3-yl)pyridine (CAS 676245-38-8)
- Semaglutide impurity 84 (CAS CATO-C4X-222684)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com